Alnylam Pharmaceuticals I... (ALNY)
267.06
11.30 (4.42%)
At close: Apr 02, 2025, 3:59 PM
261.99
-1.90%
After-hours: Apr 02, 2025, 06:07 PM EDT
Alnylam Pharmaceuticals Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 |
| Net Income | -278.16M | -440.24M | -1.13B | -852.82M | -858.28M | -886.12M | -761.5M | -490.87M | -410.11M | -290.07M | -360.39M | -89.22M | -106.01M | -57.65M | -43.52M | -47.59M | -26.25M | -85.47M | -34.61M | -42.91M | -32.65M | -25.03M | -4.14M |
| Depreciation & Amortization | 56.67M | 97.03M | 85.55M | 89.69M | 74.44M | 54.37M | 6.43M | 13.37M | 15.13M | 19.05M | 11.93M | 10.23M | 9.04M | 5.13M | 4.94M | 5.99M | 5.73M | 4.08M | 3.81M | 3.12M | 2.44M | 838K | 36K |
| Stock-Based Compensation | 272.08M | 221.68M | 230.65M | 165.72M | 139.87M | 174.84M | 157.75M | 92.82M | 75.53M | 45.78M | 33.06M | 20.7M | 12.36M | 16.8M | 19.34M | 20.17M | 18.03M | 14.47M | 8.3M | n/a | 4.11M | n/a | n/a |
| Other Working Capital | n/a | -509K | -147.59M | -122.85M | -38.41M | 422.42M | 37.02M | 1.85M | 16.76M | 2.28M | -5.84M | -6M | -6.78M | -52.42M | -76.38M | -60.31M | 65.14M | 254.68M | -4.74M | n/a | 4.41M | n/a | n/a |
| Other Non-Cash Items | 47.85M | 214.93M | 309.24M | 174.24M | 95.75M | -12.61M | -6.84M | 2.91M | 1.51M | 984K | 221.46M | 449K | 364K | 1.08M | 3.71M | 4.86M | 9.59M | 7.12M | 8.43M | 6.55M | 7.16M | 8.46M | 172K |
| Deferred Income Tax | -106.76M | n/a | n/a | -55.7M | -54.04M | -11.29M | -3.56M | 1.89M | -6.98M | n/a | -42.29M | -2.69M | -22.39M | 3.5M | 10.74M | -5.16M | -5.5M | 1.89M | -7.92M | n/a | -4.11M | n/a | n/a |
| Change in Working Capital | n/a | 10.76M | -35.55M | -162.82M | -12.7M | 402.38M | 45.1M | -2.9M | 17.22M | 35.12M | -29.4M | -8.12M | -8.96M | -55.93M | -79.56M | -50.41M | 63.9M | 254.42M | -2.65M | 16.76M | 3.48M | 2.91M | 2.65M |
| Operating Cash Flow | -8.31M | 104.16M | -541.27M | -641.69M | -614.96M | -278.43M | -562.62M | -382.79M | -307.7M | -189.14M | -165.64M | -68.66M | -115.61M | -87.07M | -84.34M | -72.14M | 65.49M | 196.52M | -24.63M | -16.48M | -19.57M | -12.83M | -1.28M |
| Capital Expenditures | -34.28M | -62.21M | -72.06M | -76.37M | -70.36M | -140.16M | -126.89M | -104.21M | -64.56M | -12.95M | -8.96M | -4.01M | -8.35M | -1.29M | -4.73M | -4.95M | -10.76M | -7.79M | -4.99M | -1.95M | -9.01M | -3.12M | -562K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25M | n/a | n/a | -81.96M | -17.84M | -10M | -100K | 2.34M | n/a | 40.42M | n/a | -121K | n/a |
| Purchase of Investments | -1.71B | -1.82B | -1.98B | -1.66B | -2.03B | -2.08B | -1.1B | -903.46M | -759.31M | -1.03B | -977.77M | -364.31M | -277.13M | -293.12M | -390.47M | -481.34M | -482.24M | -554.39M | -172.3M | -70.88M | -33.5M | n/a | n/a |
| Sales Maturities Of Investments | 1.57B | 1.55B | 2.23B | 1.46B | 1.69B | 1.78B | 1.52B | 597.3M | 1.12B | 726.94M | 462.92M | 237.81M | 289.01M | 376.37M | 413.04M | 504.57M | 511.04M | 283.25M | 147.24M | 32.41M | 7.72M | n/a | n/a |
| Other Investing Acitivies | 57.76M | -4.44M | -13.19M | -4.36M | -31.2M | 23M | -14.82M | 120M | -150M | -1.47M | -25M | -126.5M | -162K | 81.96M | 17.84M | 6.15M | -100K | -839K | n/a | -40.42M | 185K | n/a | n/a |
| Investing Cash Flow | -116.84M | -336.35M | 169.35M | -273.3M | -435.52M | -417.68M | 272.94M | -290.36M | 142.59M | -321.32M | -548.81M | -130.5M | 3.37M | 81.96M | 17.84M | 14.43M | 17.94M | -277.43M | -30.05M | -40.42M | -34.59M | -3.24M | -562K |
| Debt Repayment | n/a | n/a | 254M | 500M | 200M | n/a | n/a | -120M | 150M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.76M | -2.38M | 1.74M | 194K | 5.34M | -1.1M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -3.47M | -257K | -596K | -378K | -15.99M | -1.39M | -359K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 294.16M | 172.13M | 171.75M | 747.12M | 695.48M | 41.28M | 65.47M | 83.89M | 14.13M | 31.14M | 29.42M | 28.74M | 6.97M | 738K | 2.67M | n/a | n/a | n/a | n/a | n/a | 327K | -2.67M | -28K |
| Financial Cash Flow | 294.16M | 172.13M | 425.75M | 1.25B | 994.98M | 823.18M | 65.47M | 1.12B | 177.83M | 616.18M | 736.47M | 200.93M | 93.41M | 738K | 3.66M | 3.51M | 3.15M | 58.63M | 166.63M | 52.62M | 50.98M | 23.71M | 17.32M |
| Net Cash Flow | 153.77M | -53.67M | 46.4M | 323.11M | -50.58M | 127M | -224.2M | 451.74M | 12.72M | 105.72M | 22.01M | 1.76M | -18.82M | -4.37M | -62.87M | -54.32M | 86.64M | -22.8M | 112.2M | -4.51M | -2.92M | 7.72M | 17.32M |
| Free Cash Flow | -42.59M | 41.95M | -613.33M | -718.07M | -685.32M | -418.58M | -689.5M | -487M | -372.26M | -202.09M | -174.6M | -72.66M | -123.96M | -88.36M | -89.07M | -77.09M | 54.73M | 188.73M | -29.62M | -18.43M | -28.58M | -15.95M | -1.84M |